November 10, 2022 | 2:00 - 3:00 PM
Virtual Event | Zoom
The Neuroscience Biomarker Program is dedicated to advancing biomarkers for neurological disease. The program is focused on supporting research to promote biomarkers that will improve the quality and efficiency of Phase II clinical trials and clinical practice. The NINDS Biomarker Program provides support for biomarker and endpoint discovery, along with analytical and clinical validation in a manner that is consistent with FDA guidelines.
Contact:
Dr. Carol Taylor-Burds
carol.taylor-burds@nih.gov